IV Glofitamab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: RO7082859

Filter by location:

San Francisco, California1 trial

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.